P47.11 COMPEL: Chemotherapy With/Without Osimertinib in Patients With EGFRm Advanced NSCLC and Progression on First-Line Osimertinib
Lecia V. Sequist, Nir Peled, Amanda Tufman, Leslie Servidio, J. Li, R. Taylor, Jun Zhao
Topics & Concepts
OsimertinibMedicineT790MLung cancerChemotherapyOncologyInternal medicineTyrosine-kinase inhibitorEpidermal growth factor receptorTyrosine kinaseCancer researchCancerReceptorErlotinibGefitinibLung Cancer Treatments and MutationsColorectal Cancer Treatments and StudiesGastric Cancer Management and Outcomes